focus -WSS

focus

author：hotspot 2025-09-30 22:28:22 - browse：4

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Judge rejects Trump's counterclaim against E. Jean Carroll

focus

WSS

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

Medicare’s new pay boost for primary care is angering specialists

Sage's campaign to raise awareness of postpartum depression hits a nerve

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Type 2 diabetes prevention programs work at large scale: study

Wikipedia

focus

explore

Cancer drug shortages should be causing more outrage

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A letter from the executive editor: STAT UnitedHealth investigation

Heart attack and stroke risk calculators need revising

UnitedHealth sued over use of algorithm in Medicare Advantage plans

DIEP, the 'gold standard' of breast reconstruction, is under threat

Discs beat pads, tampons for heavy menstrual flow, new study shows

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

focus

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

First transplant of an entire human eye performed

Astronauts get first look at the spacecraft that will fly them around the moon

First transplant of an entire human eye performed

Cancer diagnosis changes perspective doctor, former hospital CEO

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

leisure time

hotspot

focus

focus